Wei-Guo Zhao

Wei-Guo Zhao

Auto-generated profile, based on publicly available information

Wei-Guo Zhao

Department of pharmacy of Zhongshan City People’s Hospital, Zhongshan, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2015 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
WZWenyuan Zhang
Wenyuan Zhang
YLYing-ran Li
Ying-ran Li
YLYun-Jing Li
Yun-Jing Li
XLXue-Qin Li
Xue-Qin Li
WZWei-Guo Zhao
Wei-Guo Zhao
RLRong-Zhi Lu
Rong-Zhi Lu
An essential medicine (EM) system has been implemented in China to reduce patients’ financial burden and to make the use of drugs more rational. This study aims to evaluate the current state of the EM system in Guangdong Province. We conducted surveys in 21 cities in 2012, covering 98 medical institutions, 1,509 doctors, 17 medicine manufacturers, and 17 distribution companies. We also reviewed outpatient prescriptions (n = 9,941) for treating hypertension, diabetes, bacterial infections and gout to measure the rational use of drugs in secondary and tertiary (upper-level) hospitals. The percentage of non-priority EM use ranged from 8.1% to 10.7% in upper-level hospitals, and this non-priority use significantly increased prescription drug costs. Other types of inappropriate medicine use were found more frequently in treating bacterial infections (7.4%) than in treating hypertension (1.6%), diabetes (1.3%) and gout (1.7%). Tertiary hospitals prescribed fewer EMs than secondary hospitals; moreover, tertiary hospitals had higher prescription drug costs. The zero mark-up policy decreased prescription drug costs in secondary hospitals. The survey revealed that forced full-prescription EM use might lead to fewer patient visits to primary hospitals. Manufacturers had halted the production of four (1, 23) types of EMs at the time of the survey. Encouraging the priority use of EMs and implementation of the zero mark-up policy were effective in curtailing prescription medicine costs in upper-level hospitals. Further work should focus on the following: creating guidelines to enhance rational prescription behavior, establishing policies to support EM use in upper-level hospitals and improving the bidding system to ensure a steady supply of the lowest-priced generic drugs.

31 January 2026 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
LCLinmu Chen
Linmu Chen
YHYunxiu Huang
Yunxiu Huang
WZWeiguo Zhao
Weiguo Zhao
Patients with sepsis and concurrent methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection face a substantial risk of mortality. This stu